8-iso-17-phenyl trinor Prostaglandin F2β

3-(1-(S)-(N,N-二甲基氨基)乙基)苯酚;(S)-3-[1-(二甲氨基)乙基]苯酚;卡巴拉汀(利斯的明)中间体 三;(S)-3-[1-(二甲氨基)]苯酚;利斯的明中间体 九;3-[1-(S)-(N,N-二甲氨基) 乙基] 苯酚;(S)-3-1-(二甲氨基)苯酚;(S)-3-(1-(N,N-二甲基氨基)乙基)苯酚;(S)-3-[1-(Dimethylamino)ethyl]phenol (S)-3-[1-(二甲氨基)乙基]苯酚;(S)-3-[1-(二甲基氨基)乙基]苯酚;3-(1-(S)-(N,N-二甲基氨基)乙基)苯酚盐酸盐;NAP226-90(利斯明EP杂质A);酒石酸卡巴拉汀杂质A(EP) 标准品;卡巴拉汀相关物质C;利凡斯的明杂质C;3-(1-(S)-(N,N-二甲基氨基)乙基)苯酚 中文别名： (S)-3-[1-(二甲氨基)乙基]苯酚;3-(1-(S)-(N,N-基氨基)乙基)苯酚;3-[1-(S)-(N,N-二甲基氨基)乙基]苯酚;S-3-(1-(N,N-二甲基氨基)乙基)苯酚;酒石酸卡巴拉汀;卡巴拉汀(利斯的明)中间体异构体7(氧化物);利凡斯的明中间体-1;利斯的明中间体

8-iso-17-phenyl trinor Prostaglandin F2β

(S)-3-(1-(Dimethylamino)ethyl)phenol;(S)-3-1(-DIMETHYLAMINO)ETHYLPHENOL;RIVASTIGMINE METABOLITE;NAP 226-90;3-((S)-1-DIMETHYLAMINO-ETHYL)-PHENOL;Rivastigmine Intermediate 3;Rivastigmine Intermediate 9;3-[(1S)1-(DIMETHYLAMINO)ETHYL]PHENOL(INTERMEDIATEOFRIVASTIGMINE);S-3-(1-dimethylaminoethyl)phenol;(S)-3-1-(Dimethylamino)Ethylphenol;(S)-3-[1-(Dimethylamino)ethyl]phenol;(S)-3-(1-(dimethylami)ethyl)phel;(S)-3-(1-Dimethylaminoethyl)phenol;3-[(1(S)-N,N-Dimethylamino)Ethyl] Phenol;3-[(1S)-1-(dimethylamino)ethyl]phenol;3-[(1S)-1-(DIMETHYLAMINOETHYL)]PHENOL;Phenol, 3-[(1S)-1-(dimethylamino)ethyl]-;Rivastigmine Decarbamylated;TyrphostinRG14620;Rivastigmine Related Compound C;SAF;(S)-3-1(- Dimethylamino)ethylphenol;1608PLR9ZO;3-((1S)-1-(Dimethylamino)ethyl)phenol;Phenol, 3-((1S)-1-(dimethylamino)ethyl)-;(S)-

139306-10-8

C₁₀H₁₅NO

165.23